SLU-PP-332 vs RAD-140: Exercise Mimetic Peptide vs SARM in Performance Research

SLU-PP-332 vs RAD-140: Two Distinct Approaches to Performance and Body Composition Research

The comparison of SLU-PP-332 vs RAD-140 represents a fascinating contrast between cutting-edge peptide science and traditional androgen receptor pharmacology. SLU-PP-332, a first-in-class estrogen-related receptor (ERR) agonist, produces exercise-like metabolic effects without muscle contraction. RAD-140, a selective androgen receptor modulator (SARM), drives muscle hypertrophy through androgen signaling. This guide examines their divergent mechanisms, research evidence, and implications.

Explore SLU-PP-332 and our full catalog of research peptides at our research hub.

SLU-PP-332: The Exercise Mimetic

Mechanism of Action

SLU-PP-332 activates all three estrogen-related receptor isoforms (ERR?, ERR?, ERR?) — orphan nuclear receptors that serve as master transcriptional regulators of mitochondrial function, oxidative metabolism, and energy homeostasis. Unlike estrogen receptors, ERRs do not bind estrogen; they are constitutively active transcription factors that regulate genes governing:

• Mitochondrial biogenesis: Upregulation of PGC-1?, NRF-1, and TFAM, increasing mitochondrial number and function
• Fatty acid oxidation: Enhanced expression of CPT1, MCAD, and VLCAD enzymes in the beta-oxidation pathway
• Oxidative phosphorylation: Increased expression of electron transport chain complexes I-V
• Muscle fiber type switching: Transition from fast-twitch glycolytic (Type IIx) to slow-twitch oxidative (Type I) fibers

Key Research Findings

A landmark 2023 study in Nature by Cho et al. demonstrated that SLU-PP-332 treatment in sedentary mice produced effects resembling endurance training:

• ~50% improvement in running endurance without any exercise
• Resistance to diet-induced obesity on high-fat diets
• Muscle fiber type switching toward oxidative fibers
• Enhanced fat oxidation and reduced fat mass (Cho et al., 2023)

RAD-140: The Selective Androgen Receptor Modulator

Mechanism of Action

RAD-140 (Testolone) binds to androgen receptors with high affinity and tissue selectivity, preferentially activating anabolic gene expression in skeletal muscle and bone while showing reduced androgenic activity in prostate and reproductive tissues. The selectivity arises from differential cofactor recruitment in different tissue contexts (Miller et al., 2011).

Key Research Findings

• Increased lean body mass in castrated rats comparable to testosterone propionate
• Anabolic effects on cortical bone in ovariectomized models
• Neuroprotective effects via AR-mediated pathways in hippocampal neurons (Jayaraman et al., 2014)

Head-to-Head Comparison

The Fundamental Difference: Metabolic Reprogramming vs Anabolic Growth

SLU-PP-332 and RAD-140 represent opposite philosophies in performance research. SLU-PP-332 reprograms cellular metabolism to favor oxidative efficiency — it makes existing muscle fibers more metabolically active without necessarily increasing their size. RAD-140 drives hypertrophy — increasing muscle fiber cross-sectional area through AR-mediated protein synthesis without fundamentally changing metabolic programming.

This distinction has practical implications: SLU-PP-332 research is most relevant to endurance, metabolic health, and obesity models, while RAD-140 research targets muscle wasting, sarcopenia, and anabolic models.

Combining Exercise Mimetics with Other Peptides

SLU-PP-332’s metabolic pathway is entirely independent of the mechanisms used by other research peptides, suggesting potential for combination studies:

• SLU-PP-332 + MOTS-C: Both activate AMPK through different upstream mechanisms (ERR vs folate cycle), potentially producing additive metabolic effects
• SLU-PP-332 + AOD 9604: ERR-mediated fat oxidation combined with GH fragment-mediated lipolysis targets two independent fat metabolism pathways
• SLU-PP-332 + Semaglutide: Exercise mimetic effects combined with appetite-mediated weight loss could address both energy expenditure and energy intake

Frequently Asked Questions

Does SLU-PP-332 build muscle like RAD-140?

SLU-PP-332 does not directly increase muscle mass through anabolic pathways. Instead, it remodels existing muscle fibers toward an oxidative phenotype, improving endurance and fat burning capacity. RAD-140 directly increases muscle cross-sectional area through androgen receptor-mediated protein synthesis.

Is SLU-PP-332 safer than RAD-140?

Based on available data, SLU-PP-332 appears to have a more favorable safety profile. It does not suppress the HPG axis, has no reported hepatotoxicity, and works through nuclear receptor transcription rather than hormonal manipulation. RAD-140 has documented liver injury cases and suppresses endogenous testosterone.

Can SLU-PP-332 replace exercise?

In preclinical models, SLU-PP-332 produced many molecular and functional adaptations similar to endurance training, including improved running performance in sedentary mice. However, exercise produces benefits beyond metabolic reprogramming (cardiovascular, neurological, psychological) that a single compound cannot fully replicate.

Conclusion

SLU-PP-332 vs RAD-140 illustrates the contrast between metabolic reprogramming and direct anabolic stimulation. For researchers studying endurance, metabolism, and obesity, SLU-PP-332 offers a novel exercise-mimetic approach without hormonal disruption. RAD-140 remains relevant for muscle mass and androgen receptor biology research, but with documented safety concerns. Explore our complete research peptide catalog and browse the research hub.